Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Hodgkin Disease × Neuropsychological Tests × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1 Localized, Operable Non-small Cell Lung Cancer 1 Hodgkin Disease 1

Interventions

tislelizumab 2 pembrolizumab 2 fludarabine phosphate 2 fludarabine 2 Cyclophosphamide 2 sintilimab 1 sargramostim 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 liposomal doxorubicin 1 letermovir 1 Vinorelbine 1 Stem Cell Transplantation 1 Specimen Handling 1 Rituximab 1 Radiotherapy 1 Ocoxin 1 Neuropsychological Tests 1 Magnetic Resonance Spectroscopy 1 High-Intensity Interval Training 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 Brentuximab Vedotin 1 Bone Marrow Purging 1 Blood Component Removal 1 Bendamustine Hydrochloride 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06116929 2024-02-28

FunC-AHOD

Lille Catholic University

Phase NA Not yet recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡